These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36177579)
21. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146 [TBL] [Abstract][Full Text] [Related]
22. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study. Gerber RS; Fazzari M; Kappy M; Cohen A; Galperin S; Lieman H; Jindal S; Buyuk E Fertil Steril; 2020 Dec; 114(6):1225-1231. PubMed ID: 33012553 [TBL] [Abstract][Full Text] [Related]
23. Assessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment. Abdulrahim B; Scotland G; Bhattacharya S; Maheshwari A Hum Reprod; 2021 Oct; 36(11):2891-2903. PubMed ID: 34550368 [TBL] [Abstract][Full Text] [Related]
25. Perinatal complications and live-birth outcomes following assisted reproductive technology: a retrospective cohort study. Lei LL; Lan YL; Wang SY; Feng W; Zhai ZJ Chin Med J (Engl); 2019 Oct; 132(20):2408-2416. PubMed ID: 31634242 [TBL] [Abstract][Full Text] [Related]
26. Risk of gestational hypertension in pregnancies complicated with ovarian hyperstimulation syndrome. Dobrosavljevic A; Rakic S J Pak Med Assoc; 2020 Nov; 70(11):1897-1900. PubMed ID: 33341826 [TBL] [Abstract][Full Text] [Related]
27. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS. Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582 [TBL] [Abstract][Full Text] [Related]
28. Fresh versus frozen embryo transfers in assisted reproduction. Wong KM; van Wely M; Mol F; Repping S; Mastenbroek S Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011184. PubMed ID: 28349510 [TBL] [Abstract][Full Text] [Related]
29. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114 [TBL] [Abstract][Full Text] [Related]
30. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome. Christopoulos G; Vlismas A; Carby A; Lavery S; Trew G Hum Fertil (Camb); 2016 Sep; 19(3):199-206. PubMed ID: 27662416 [TBL] [Abstract][Full Text] [Related]
31. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL; Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350 [TBL] [Abstract][Full Text] [Related]
32. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Youssef MA; Mourad S Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848 [TBL] [Abstract][Full Text] [Related]
33. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles. Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223 [TBL] [Abstract][Full Text] [Related]
34. Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data. Sunkara SK; LaMarca A; Polyzos NP; Seed PT; Khalaf Y Hum Reprod; 2016 Oct; 31(10):2261-7. PubMed ID: 27591229 [TBL] [Abstract][Full Text] [Related]
35. Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study. Fouda UM; Elshaer HS; Youssef GG; Hanafy A; Mehrem WM; Youssef MA; Farouk M; Nabil H J Obstet Gynaecol; 2022 Jan; 42(1):122-126. PubMed ID: 34270379 [TBL] [Abstract][Full Text] [Related]
37. Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome. Tomazevic T; Meden-Vrtovec H J Assist Reprod Genet; 1996 Apr; 13(4):282-6. PubMed ID: 8777340 [TBL] [Abstract][Full Text] [Related]
38. Elective frozen-thawed embryo transfer (FET) in women at risk for ovarian hyperstimulation syndrome. Zech J; Brandao A; Zech M; Lugger K; Neururer S; Ulmer H; Ruttmann-Ulmer E Reprod Biol; 2018 Mar; 18(1):46-52. PubMed ID: 29279182 [TBL] [Abstract][Full Text] [Related]
39. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Walls ML; Hunter T; Ryan JP; Keelan JA; Nathan E; Hart RJ Hum Reprod; 2015 Jan; 30(1):88-96. PubMed ID: 25355587 [TBL] [Abstract][Full Text] [Related]
40. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Kwan I; Bhattacharya S; McNeil A; van Rumste MM Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]